Cour Pharmaceuticals Development

0 followers

‌

Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.

Industries

Biotechnology, Pharmaceutical

Headquarters

Elmhurst, United States

Employees

11-50

Links

Org chart

John J. Puisis

Co-Founder & President & CEO

John J. Puisis

Collapse

Brian C. Bock

CFO

Adam Elhofy

VP, Immunology & Innovation

Robert Hodge

VP of Technical Development

Pooja Agashe

Intellectual Property and Business Analyst

Lori Jester

Vice President Of Manufacturing And Supply Chain

Teams

Advisory and Executive Roles

12 members

Research and Development

10 members

Leadership Team

8 members

Finance and Accounting

4 members

Regulatory Affairs and Compliance

3 members

Similar companies

Amgen

227 followers

VaxCare

1 follower

Enko

4 followers

Tessera Therapeutics

2 followers

Rocket Pharmaceuticals

2 followers

Vaxcyte

2 followers

Tango Therapeutics

2 followers

Kyverna Therapeutics

6 followers

AbbVie

188 followers

Ultima Genomics

3 followers

Incyte

16 followers

Explore companies